{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-269567","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2026-06-12T20:36:30+00:00","discovered_at":"2026-06-12T20:37:00.477661+00:00","generated_at":"2026-06-12T20:54:43.165101+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Climb Bio enters $100M ATM equity facility with Jefferies, terminates prior Oppenheimer agreement","bullets":["Enters $100M at-the-market equity distribution agreement with Jefferies LLC for common stock sales.","Jefferies will receive up to 3.0% of gross sales price per share; proceeds to fund general corporate purposes.","Terminates prior $22.35M ATM facility with Oppenheimer & Co.; no shares were sold, no penalties incurred.","Shares sold from time to time on Nasdaq Global Market at prevailing market prices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-269567","json":"https://secwatch.observer/filing/0001193125-26-269567.json","markdown":"https://secwatch.observer/filing/0001193125-26-269567.md","text":"https://secwatch.observer/filing/0001193125-26-269567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/0001193125-26-269567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/d92589d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:54:43.165101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ee1c12d0c73cba65439b4a6a4de2b38c0edecff","claim":"Climb Bio, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $100.0 million in aggregate offering price (effective 2026-06-12).","evidence_excerpt":"On June 12, 2026, Climb Bio, Inc., a Delaware corporation (the “Company”), entered into an Open Market Sale AgreementSM (the “Sales Agreement”) with Jefferies LLC, as agent (“Jefferies”), pursuant to which the Company may offer and sell shares of its common stock, $0.0001 par value per share (the “Common Stock”), from time to time through Jefferies.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/0001193125-26-269567-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Jefferies LLC"},{"label":"Value","value":"up to $100.0 million in aggregate offering price"},{"label":"Effective","value":"2026-06-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}